We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

167 hedge funds and large institutions have $433M invested in BioTelemetry, Inc. in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 55 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 15

21% more capital invested

Capital invested by funds: $358M → $433M (+$75.1M)

20% more funds holding

Funds holding: 139167 (+28)

5% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 58

15% less call options, than puts

Call options by funds: $3.88M | Put options by funds: $4.58M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
167
Holders Change
+28
Holders Change %
+20.14%
% of All Funds
4.44%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
43
Increased
55
Reduced
58
Closed
15
Calls
$3.88M
Puts
$4.58M
Net Calls
-$697K
Net Calls Change
+$1.01M

BEAT Hedge Fund Activity: Q3 2016 in Review

167 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2016, worth a combined $433M — up 21% from $358M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new BEAT positions and 15 closed out — a net gain of 28 holders — while 55 added to existing stakes and 58 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $23.3M. The largest seller was Cannell Capital, cutting an estimated $7.91M.

  • 167 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2016, up from 139 in Q2 2016.
  • Funds reported $433M of BioTelemetry, Inc. stock for Q3 2016, up 21% quarter-over-quarter.
  • 43 funds opened new BioTelemetry, Inc. positions in Q3 2016 and 15 closed out, a net change of +28 holders.
  • The largest BioTelemetry, Inc. buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $23.3M added.
  • The largest BioTelemetry, Inc. seller in Q3 2016 was Cannell Capital, an estimated $7.91M sold.

Based on aggregated 13F filings for Q3 2016.